| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 125.20B | 119.16B | 118.68B | 92.86B | 90.71B | 68.23B |
| Gross Profit | 41.06B | 36.35B | 35.51B | 18.62B | 17.67B | 15.37B |
| EBITDA | 37.36B | 31.42B | 31.36B | 14.11B | 13.82B | 13.15B |
| Net Income | 15.80B | 14.73B | 12.29B | 3.62B | 5.20B | 4.74B |
Balance Sheet | ||||||
| Total Assets | 168.01B | 171.26B | 162.05B | 142.16B | 132.29B | 129.52B |
| Cash, Cash Equivalents and Short-Term Investments | 31.37B | 33.68B | 30.38B | 21.13B | 24.14B | 24.48B |
| Total Debt | 66.41B | 60.39B | 61.47B | 53.38B | 49.09B | 48.42B |
| Total Liabilities | 88.85B | 85.99B | 86.62B | 73.07B | 65.15B | 65.35B |
| Stockholders Equity | 76.94B | 82.89B | 73.16B | 67.14B | 65.48B | 62.59B |
Cash Flow | ||||||
| Free Cash Flow | -2.73B | 11.95B | 7.88B | 236.00M | 3.48B | 6.59B |
| Operating Cash Flow | 190.50M | 28.54B | 19.84B | 12.19B | 9.18B | 11.02B |
| Investing Cash Flow | -2.93B | -18.82B | -11.88B | -16.75B | -6.69B | -2.08B |
| Financing Cash Flow | 3.00B | -6.43B | 1.31B | 1.54B | -2.83B | -3.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥201.22B | 22.33 | 11.00% | 2.20% | 6.75% | -0.16% | |
73 Outperform | ¥25.83B | 8.53 | ― | 2.62% | -14.20% | 231.20% | |
72 Outperform | ¥421.05B | 24.29 | ― | 1.30% | 9.57% | 9.73% | |
67 Neutral | ¥74.23B | 7.12 | ― | 2.77% | 0.41% | 25.80% | |
67 Neutral | ¥7.36B | 57.57 | ― | 1.36% | -4.59% | -14.60% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥8.85B | 6.25 | ― | 3.34% | 2.40% | -27.27% |